CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > Sexual Health   
Sexual Health
Journal Banner
  Publishing on sexual health from the widest perspective
 
blank image Search
 
blank image blank image
blank image
 
  Advanced Search
   

Journal Home
About the Journal
Editorial Committee
Contacts
Content
Online Early
Current Issue
Just Accepted
All Issues
Special Issues
Sample Issue
Call for Papers
For Authors
General Information
Instructions to Authors
Submit Article
Open Access
For Referees
Referee Guidelines
Review an Article
Annual Referee Index
For Advertisers
For Subscribers
Subscription Prices
Customer Service

blue arrow e-Alerts
blank image
Subscribe to our Email Alert or RSS feeds for the latest journal papers.

red arrow Connect with us
blank image
facebook twitter youtube

red arrow Interview with Kit Fairley
blank image
Hear Kit Fairley speak about what is sexual health.

red arrow Call for Papers
blank image
We are seeking contributions for a Special Issue. More

 

Article << Previous     |     Next >>   Contents Vol 9(6)

Why a special issue on anal cancer and what is in it?

Christopher K. Fairley A B F , Julia M. L. Brotherton B C , Richard Hillman D and Andrew E. Grulich E

A Melbourne Sexual Health Centre, Alfred Health, Melbourne, Vic. 3053, Australia.
B School of Population Health, University of Melbourne, Melbourne, Vic. 3010, Australia.
C Victorian Cytology Service, East Melbourne, Vic. 8002, Australia.
D Western Sydney Sexual Health Centre, University of Sydney, 162 Marsden Street, Parramatta, NSW 2150, Australia.
E Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
F Corresponding author. Email: cfairley@mshc.org.au

Sexual Health 9(6) 501-503 http://dx.doi.org/10.1071/SH12109
Submitted: 10 July 2012  Accepted: 3 September 2012   Published: 27 November 2012


 
 Full Text
 PDF (173 KB)
 Export Citation
 Print
  
Abstract

This editorial describes the contents of this special issue of Sexual Health devoted to anal cancer. The aim of the issue is to provide readers with information to assist them in making decisions about what to do about detecting anal cancer early in men who have sex with men with HIV. Should they be advocating screening? It discusses the epidemiology of HPV infection, anal intraepithelial neoplasia, and anal cancer in MSM, heterosexual men and women; anal cancer screening and treatment of anal cancer. And most importantly, what should be done about vaccinating boys with the HPV vaccine.



References

[1]  Grulich AE, Poynten IM, Machalek DA, Jin F, Templeton DJ, Hillman RJ. The epidemiology of anal cancer. Sex Health 2012; 9: 504–8.

[2]  Machalek DA, et al Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012; 13: 487–500.
CrossRef |

[3]  Poynten IM, Stein AN, Conway EL, Prestage G, Regan DG, Jin F, Hocking J. Poynten IM, Stein AN, Conway EL, Prestage G, Regan DG, Jin F, Hocking J. Geographical clustering of anal cancer incidence in Australia. Sex Health 2012; 9: 509–12.
CrossRef |

[4]  Jin F, et al Trends in anal cancer in Australia, 1982–2005. Vaccine 2011; 29: 2322–7.
CrossRef |

[5]  Pandey P. Anal anatomy and normal histology. Sex Health 2012; 9: 513–16.

[6]  Heywood W, Smith AMA. Anal sex practices in heterosexual and male homosexual populations: a review of population-based data. Sex Health 2012; 9: 517–26.

[7]  Machalek DA, Grulich AE, Jin F, Templeton DA, Poynten IM. The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men. Sex Health 2012; 9: 527–37.

[8]  Nyitray AG. The epidemiology of anal human papillomavirus infection among women and men having sex with women. Sex Health 2012; 9: 538–46.
CrossRef |

[9]  Coutlée F, de Pokomandy A, Franco EL. Epidemiology, natural history and risk factors for anal intraepithelial neoplasia. Sex Health 2012; 9: 547–55.

[10]  Roberts JM, Ekman D. The reporting of anal cytology and histology samples: establishing terminology and criteria. Sex Health 2012; 9: 562–67.

[11]  Roberts JM, Thurloe JK. Comparison of performance of anal cytology and cervical cytology as screening tests. Sex Health 2012; 9: 568–73.
CrossRef |

[12]  Darragh TM, Winkler B. Screening for anal neoplasia: anal cytology – sampling, processing, and reporting. Sex Health 2012; 9: 556–61.
CrossRef |

[13]  Hillman RJ, van Leeuwen MT, Vajdic CM, McHugh L, Prestage GP, Botes LP. Hillman RJ, van Leeuwen MT, Vajdic CM, McHugh L, Prestage GP, Botes LP. Prevalence and predictors of high-grade anal intraepithelial neoplasia in a community-based sample of homosexual men. Sex Health 2012; 9: 574–79.

[14]  Palefsky JM. Practising high-resolution anoscopy. Sex Health 2012; 9: 580–86.

[15]  Fox PA. Treatment options for anal intraepithelial neoplasia and evidence for their effectiveness. Sex Health 2012; 9: 587–92.
CrossRef |

[16]  Szmulowicz UM, Wu JS. Squamous cell carcinoma of the anal canal: a review of the aetiology, presentation, staging, prognosis and methods available for treatment. Sex Health 2012; 9: 593–609.

[17]  Howard K. The cost-effectiveness of screening for anal cancer in men who have sex with men: a systematic review. Sex Health 2012; 9: 610–19.
CrossRef |

[18]  Landstra JMB, Ciarrochi J, Deane FP. Psychosocial aspects of anal cancer screening: a review and recommendations. Sex Health 2012; 9: 620–27.

[19]  Palefsky JM, et al HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365: 1576–85.
CrossRef |

[20]  Donovan B, et al Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011; 11: 39–44.
CrossRef |

[21]  Read TR, et al The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 2011; 87: 544–7.
CrossRef |

[22]  Simatherai D, et al What men who have sex with men think about the human papillomavirus vaccine. Sex Transm Infect 2009; 85: 148–9.
CrossRef |

[23]  Conly JM, Shafran S. Targeted versus universal vaccination against hepatitis B: a paradigm shift. Can J Infect Dis Med Microbiol 1993; 4: 171–2.

[24]  Department of Health and Ageing (DoHA). Positive recommendations on pharmaceutical benefits scheme – Pharmaceutical Benefits Advisory Committee (PBAC) in November 2011. Canberra: DoHA; 2012. Available online at: http://www.health.gov.au/internet/main/publishing.nsf/Content/pbacrec-nov11-positive [verified July 2012].

[25]  Grulich AE, et al Cancers attributable to human papillomavirus infection. Sex Health 2010; 7: 244–52.
CrossRef |

[26]  Grulich AE, Hillman R, Brotherton JML, Fairley CK, et al Time for a strategic research response. Sex Health 2012; 9: 628–631.


   
 
    
Legal & Privacy | Contact Us | Help

CSIRO

© CSIRO 1996-2014